KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $212.3 million.

  • West Pharmaceutical Services' Long-Term Investments rose 504.7% to $212.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $212.3 million, marking a year-over-year increase of 504.7%. This contributed to the annual value of $212.3 million for FY2025, which is 504.7% up from last year.
  • Per West Pharmaceutical Services' latest filing, its Long-Term Investments stood at $212.3 million for Q4 2025, which was up 504.7% from $220.9 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Long-Term Investments peaked at $224.7 million during Q2 2025, and registered a low of $188.6 million during Q3 2022.
  • Its 5-year average for Long-Term Investments is $207.4 million, with a median of $208.4 million in 2022.
  • As far as peak fluctuations go, West Pharmaceutical Services' Long-Term Investments crashed by 1256.37% in 2022, and later soared by 1337.03% in 2025.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Long-Term Investments stood at $207.7 million in 2021, then decreased by 1.35% to $204.9 million in 2022, then rose by 2.49% to $210.0 million in 2023, then decreased by 3.76% to $202.1 million in 2024, then increased by 5.05% to $212.3 million in 2025.
  • Its Long-Term Investments stands at $212.3 million for Q4 2025, versus $220.9 million for Q3 2025 and $224.7 million for Q2 2025.